Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA

Pharmaceutical Research

Volumn 16, Issue 4, 1999, Pages 509-513

  Capan, Yilmaz ^a   Woo, Byung H ^a   Gebrekidan, Sisay ^a   Ahmed, Shamim ^a   DeLuca, Patrick P ^a  

^a University of Kentucky   (United States)

Author keywords

Controlled release; DNA; DNA poly(L lysine) complex; Microspheres; Poly(lactide co glycolide)

Indexed keywords

DEOXYRIBONUCLEASE I; LIPOSOME; MICROSPHERE; PLASMID DNA; POLYGLACTIN; POLYLYSINE; POLYMER;

ARTICLE; BIODEGRADATION; CONTROLLED RELEASE FORMULATION; DNA CONFORMATION; DNA STRUCTURE; DRUG DELIVERY SYSTEM; IMMUNOGENICITY; PARTICLE SIZE; PRIORITY JOURNAL; RETROVIRUS;

EID: 0032902891     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018862827426     Document Type: Article

References (15)

1. 1. R. J. McDonald, H. D. Liggitt, L. Roche, H. T. Nguyen, R. Pearlman, O. G. Raabe, L. B. Bussey, and C. M. Gorman. Aerosol Delivery of lipid:DNA complexes to lungs of Rhesus monkeys. Pharm. Res. 15:671-678 (1998).
2. 2. A. Ido, K. Nakata, Y. Kato, K. Nakao, K. Murata, M. Fujita, N. Ishii, T. Tamaoki, H. Shiku, and S. Nagataki. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promotor. Cancer Res. 55:3105-3109 (1995).
3. 3. G. S. Harrison, C. J. Long, T. J. Curiel, F. Maxwell, and I. H. Maxwell. Inhibition of human immunodeficiency virus-1: Production resulting from transduction with a retrovirus containing an HIV-regulaled diphtheria toxin A chain gene. Hum. Gene Ther. 3:461-469 (1992).
4. 4. J. M. Friedman, L. E. Babiss, D. F. Clayton, and J. E. Darnell. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol. Cell. Biol. 6:3791-3797 (1986).
5. 5. M. Cotten and E. Wagner. Non-viral approaches to gene therapy. Curr. Opin. Biotechnol. 4:705-710 (1993).
6. 6. R. I. Mahato, A. Rolland, and E. Tomlinson. Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm. Res. 14:853-859 (1997).
7. 7. D. H. Jones, S. Corris, S. McDonald, J. C. S. Clegg, and G. H. Farrar. Poly (D,L-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15:814-817 (1997).
8. 8. K. Kawabata, Y. Takakura, and M. Hashida. The fate of plasmid DNA after intravenous injection in mice. Involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12:825-830 (1995).
9. 9. R. C. Adami, W. T. Collard, S. A. Gupta, K. Y. Kwok, J. Bonadio, and K. G. Rice. Stability of peptide-condensed plasmid DNA formulations. J. Pharm. Sci. 87:678-683 (1998).
10. 10. M. Yoshida, R. I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharm. Res. 13:599-603 (1996).
11. 11. R. C. Mehta, R. Jeyanthi, S. Calis, B. C. Thannoo, K. W. Burton, and P. P. DeLuca. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. J. Contr. Rel. 29:375-384 (1994).
12. 12. H. L. Davis, R. G. Whalen, and B. A. Demeneix. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene. Ther. 4:733-740 (1993).
13. 13. R. Jeyanthi, B. C. Thanoo, R. C. Mehta, and P. P. DeLuca. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspsheres for peptide delivery. J. Contr. Rel. 38:235-244 (1996).
14. 14. J. Hermann and R. Bodmeier. Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on w/o/w-multiple emulsions. Int. J. Pharm. 126:129-138 (1995).
15. 15. C. W. Pouton, P. Lucas, B. J. Thomas, A. N. Uduehi, D. A. Milray, and S. H. Moss. Polycation-DNA complex for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Contr. Rel. 53:289-299 (1998).